CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke
Jay Chol Choi, Ji Sung Lee, Tai Hwan Park, Sang-Soon Park, Yong-Jin Cho, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Soo-Joo Lee, Youngchai Ko, Jae Guk Kim, Jun Lee, Ki-Hyun Cho, Joon-Tae Kim, Kyung-Ho Yu, Byung-Chul Lee, Mi-Sun Oh, Jae-Kwan Cha, Dae-Hyun Kim, Hyun-Wook Nah, Dong-Eog Kim, Wi-Sun Ryu, Beom Joon Kim, Hee-Joon Bae, Wook-Joo Kim, Dong-Ick Shin, Min-Ju Yeo, Sung Il Sohn, Jeong-Ho Hong, Juneyoung Lee, Keun-Sik Hong
J Stroke. 2015;17(3):327-335.   Published online September 30, 2015
DOI: https://doi.org/10.5853/jos.2015.17.3.327

Excel Download

Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke
Marc Quinlan
The Journal of Emergency Medicine. 2013;45(5):810   Crossref logo
Link1 Link2
Consensus Statement on the Use of Intravenous Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke by the Chinese Stroke Therapy Expert Panel
An-Ding Xu, Yong-Jun Wang, David Z Wang,
CNS Neuroscience & Therapeutics. 2013;19(8):543-548   Crossref logo
Link1
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients
A.A. Rabinstein
Yearbook of Neurology and Neurosurgery. 2007;2007:15-17   Crossref logo
Link1 Link2
Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
A.A. Rabinstein
Yearbook of Neurology and Neurosurgery. 2011;2011:10-11   Crossref logo
Link1 Link2
Risk of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with Intravenous Tissue Plasminogen Activator
Howard Kim
The Journal of Emergency Medicine. 2012;43(5):e379   Crossref logo
Link1 Link2
0058 Circadian Variation Of The Efficacy Of Intravenous Recombinant Tissue Plasminogen Activator In Patients With Acute Ischemic Stroke
J Kim, S Lee
Sleep. 2018;41(suppl_1):A23-A24   Crossref logo
Link1
Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years
Gioia Mione, Xavier Ducrocq, Nathalie Thilly, Jean-Christophe Lacour, Hervé Vespignani, Sébastien Richard
Geriatrics & Gerontology International. 2015;16(7):843-849   Crossref logo
Link1
The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke
Julie E. Buijs, Maarten Uyttenboogaart, Raf Brouns, Jacques de Keyser, Pieter Willem Kamphuisen, Gert-Jan Luijckx
Journal of Stroke and Cerebrovascular Diseases. 2016;25(2):312-316   Crossref logo
Link1 Link2
Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry
Ryu Matsuo, Masahiro Kamouchi, Tetsuro Ago, Jun Hata, Yuji Shono, Junya Kuroda, Yoshinobu Wakisaka, Hiroshi Sugimori, Takanari Kitazono,
Geriatrics & Gerontology International. 2013;14(4):954-959   Crossref logo
Link1
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
Karen Johnston, Sherita Chapman, Prachi Mehndiratta, Michelle Johansen, Andrew Southerland, Timothy McMurry
Vascular Health and Risk Management. 2014;75   Crossref logo
Link1